Cytokine effect on ex vivo expansion of haemopoietic stem cells from different human sources

Biotherapy

Volumn 10, Issue 4, 1998, Pages 295-298

  Eridani, Sandro ^a   Mazza, Umberto ^a   Massaro, Paolo ^b   Targia, Maria Luisa La ^a   Maiolo, Anna Teresa ^a,c   Mosca, Andrea ^a,b,c  

^a CNR   (Italy)

^b Institute of Haematology   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone marrow; Cord blood; Ex vivo expansion; Haemopoietic stem cells; Peripheral blood

Indexed keywords

CD34 ANTIGEN; CYTOKINE;

ARTICLE; BONE MARROW; CELL ISOLATION; COLONY FORMING CELL; DATA ANALYSIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRESERVATION; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0031897606     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02678549     Document Type: Article

References (16)

1. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sei USA 1992; 89: 2804-2808.
2. Lange W, Henschler R, Mertelsmann R. Biological and clinical advances in stem cell expansion. Leukemia 1996; 10:943-945.
3. Scott MA, Gordon MY In search of the Haemopoietic stem cell. Br J of Haematol 1995; 90: 738-743.
4. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2844-2853.
5. Civin CI, Trischman T, Kadan NS, Davis J, Noga S, Cohen K, Duffy B, Groenewegen I, Wiley J, Law P, Hardwick A, Oldhant F, Gee A. Highly purifed CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 1996; 14: 2224-2233.
6. Emerson SG. Ex vivo expansion of hematopoietic precursor, progenitors and stem cells: the next generation of cellular therapeutics. Blood 1996; 87: 3082-3088.
7. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Caracterization and partial purification of human marrow cells capable of initiating long term hemat.opoiesis in vitro. Blood 1989; 74: 1563-1570.
8. Eridani S, Morali F. Identification of haemopoietic stem cells. Cytotechnology 1993; 11: 101-106.
9. Fritsch G, Stimpfl M, Printz D, Buchinger P, Fishmeister G, Hoecker P, Gadner H. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant 1996; 17: 169-178.
10. Miltenyi S, Muller W, Weichel W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990; 11: 231-238.
11. Terstappen LWMM, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of haemopoietic colonies derived from single nonlineage committed CD34+ CD38- progenitor cells. Blood 1991; 77: 1218-1227.
12. Shah AJ, Smogorzewska EM, Hannum C, Crooks GM. Flt-3 ligand induces proliferation of quiescent human bone marrow CD34+ CD38- cells and maintains progenitor cells in vitro. Blood 1996; 87: 3563-3570.
13. Traycoff CM, Abboud MR, Laver J, Clapp DW, Srour EF. Rapid exit from GO/GI phases of cell cycle in response to Stem Cell Factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp Haematol 1994; 22: 1264-1272.
14. Bertolini F, Lazzari L, Lauri E, Corsini C, Sirchia G. Cord blood derived hematopoietic progenitor cells retain their potential for ex vivo expansion after cryopreservation. Bone Marrow Transplantation 1995; 15: 159-161.
15. Takekoshi KJ, Oh YH, Westerman KW, London IM, Leboulch P. Retroviral transfer of a human β-globin/δ-globin hybrid gene linked to β Locus Control Region hypersensitive site 2 aimed at the gene therapy of sickle cell disease. Proc Natl Acad Sei USA 1995; 92: 3014-3018.
16. Schwarzenberger P, Spence SE, Gooya JM, Michiel D, Curiel DT, Ruscetti FW, Keller JR. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 1996; 87: 472-473.